COSOPT PF
Drug
Thea Pharma Inc.
Total Payments
$12,718
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $12,718 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12,718 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Data Evaluation Study (ADAGES) | Thea Pharma Inc. | $12,718 | 0 |
Top Doctors Receiving Payments for COSOPT PF
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Diego, CA | $12,718 | 1 |
Ad
Manufacturing Companies
- Thea Pharma Inc. $12,718
Product Information
- Type Drug
- Total Payments $12,718
- Total Doctors 0
- Transactions 1
About COSOPT PF
COSOPT PF is a drug associated with $12,718 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Thea Pharma Inc..
Payment data is available from 2022 to 2022. In 2022, $12,718 was paid across 1 transactions to 0 doctors.
The most common payment nature for COSOPT PF is "Unspecified" ($12,718, 100.0% of total).
COSOPT PF is associated with 1 research study, including "Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Data Evaluation Study (ADAGES)" ($12,718).